SAN FRANCISCO, May 29, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

Mass spectrometry, a powerful tool for studying tiny molecules, has long helped scientists unlock secrets hidden in plants, ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Presenting Author: MRK Alley, Ph.D. A copy of the poster will be available on the AN2 Therapeutics website at the following link simultaneously with the poster session Development Pipeline | AN2 ...

Viking Therapeutics faces tough obesity drug rivals, with VK2735 showing promise but an uncertain edge. Find out why VKTX ...

Agilent's Morningstar Uncertainty Rating remains Medium, thanks to its sticky end markets that should result in relatively steady demand trends in the long run, despite its dependence on one-time ...

In a dramatic new discovery, scientists found that eliminating a single amino acid from the body triggers an extreme energy ...

This study presents an important finding on the role of GATA4 in aging and OA-associated cartilage pathology. The evidence supporting the conclusions is compelling, with rigorous in vitro and in vivo ...

Eli Lilly’s acquisition of SiteOne Therapeutics comes ahead of Phase 2 testing of the startup’s lead drug candidate, which ...

Researchers have created a pipeline for discovering unique combinations of molecules that increase the effectiveness of antibiotics against drug-resistant bacteria. The team, led by scientists at the ...

Bayer announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) and granted Priority Review designation for the investigational compound ...

Additional safety signals have been identified with apremilast, with some adverse events specific to certain patient populations.